CONFIDENTIAL MARCH 201516 Initial Label Expansion Opportunity: EHS  Exertional Heat Stroke (EHS) – A leading cause of student athlete death (US) & no
{"Image DocumentName": "Initial Label Expansion Opportunity: EHS", "Image ImageDescription": "Exertional Heat Stroke (EHS) A leading cause of student athlete death (US) & non-combat military deaths. Similarities to MH. Potential for Ryanodex to be first to market for EHS if approved. Orphan drug designation for EHS. Potential for 7 years of exclusivity. Market estimated at  400M.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}